These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 27185910

  • 21. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
    Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H.
    Cancer Res; 2009 Nov 01; 69(21):8386-94. PubMed ID: 19826044
    [Abstract] [Full Text] [Related]

  • 22. Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
    Handle F, Prekovic S, Helsen C, Van den Broeck T, Smeets E, Moris L, Eerlings R, Kharraz SE, Urbanucci A, Mills IG, Joniau S, Attard G, Claessens F.
    Sci Rep; 2019 Sep 24; 9(1):13786. PubMed ID: 31551480
    [Abstract] [Full Text] [Related]

  • 23. Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
    Mout L, Moll JM, Chen M, de Morrée ES, de Ridder CMA, Gibson A, Stuurman D, Aghai A, Erkens-Schulze S, Mathijssen RHJ, Sparreboom A, de Wit R, Lolkema MP, van Weerden WM.
    Br J Cancer; 2020 Dec 24; 123(12):1715-1719. PubMed ID: 32989230
    [Abstract] [Full Text] [Related]

  • 24. Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches.
    Damodaran S, Lang JM, Jarrard DF.
    J Urol; 2019 May 24; 201(5):876-885. PubMed ID: 30747897
    [Abstract] [Full Text] [Related]

  • 25. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T.
    Cancer Res; 2009 Oct 15; 69(20):8141-9. PubMed ID: 19808968
    [Abstract] [Full Text] [Related]

  • 26. Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms.
    Centenera MM, Carter SL, Gillis JL, Marrocco-Tallarigo DL, Grose RH, Tilley WD, Butler LM.
    Endocr Relat Cancer; 2015 Oct 15; 22(5):805-18. PubMed ID: 26187127
    [Abstract] [Full Text] [Related]

  • 27. Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Liu L, Lou N, Li X, Xu G, Ruan H, Xiao W, Qiu B, Bao L, Yuan C, Huang X, Wang K, Cao Q, Chen K, Yang H, Zhang X.
    Oncol Rep; 2017 Jun 15; 37(6):3651-3659. PubMed ID: 28498452
    [Abstract] [Full Text] [Related]

  • 28. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
    Chattopadhyay I, Wang J, Qin M, Gao L, Holtz R, Vessella RL, Leach RW, Gelman IH.
    Oncotarget; 2017 Feb 07; 8(6):10324-10347. PubMed ID: 28055971
    [Abstract] [Full Text] [Related]

  • 29. Androgen receptor splicing variant 7: Beyond being a constitutively active variant.
    Shao C, Yu B, Liu Y.
    Life Sci; 2019 Oct 01; 234():116768. PubMed ID: 31445027
    [Abstract] [Full Text] [Related]

  • 30. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
    Ishikura N, Kawata H, Nishimoto A, Nakamura R, Tsunenari T, Watanabe M, Tachibana K, Shiraishi T, Yoshino H, Honma A, Emura T, Ohta M, Nakagawa T, Houjo T, Corey E, Vessella RL, Aoki Y, Sato H.
    Int J Oncol; 2015 Apr 01; 46(4):1560-72. PubMed ID: 25634071
    [Abstract] [Full Text] [Related]

  • 31. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
    Correa RG, Krajewska M, Ware CF, Gerlic M, Reed JC.
    Oncotarget; 2014 Mar 30; 5(6):1666-82. PubMed ID: 24681825
    [Abstract] [Full Text] [Related]

  • 32. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
    Itsumi M, Shiota M, Yokomizo A, Takeuchi A, Kashiwagi E, Dejima T, Inokuchi J, Tatsugami K, Uchiumi T, Naito S.
    J Mol Endocrinol; 2014 Aug 30; 53(1):31-41. PubMed ID: 24780839
    [Abstract] [Full Text] [Related]

  • 33. Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.
    Kahn B, Collazo J, Kyprianou N.
    Int J Biol Sci; 2014 Aug 30; 10(6):588-95. PubMed ID: 24948871
    [Abstract] [Full Text] [Related]

  • 34. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
    Linder A, Larsson K, Welén K, Damber JE.
    Prostate; 2020 Aug 30; 80(11):799-810. PubMed ID: 32449815
    [Abstract] [Full Text] [Related]

  • 35. BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK.
    Shafran JS, Andrieu GP, Györffy B, Denis GV.
    Mol Cancer Res; 2019 Aug 30; 17(8):1627-1638. PubMed ID: 31110158
    [Abstract] [Full Text] [Related]

  • 36. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals.
    Tang M, Gao S, Zhang L, Liu B, Li J, Wang Z, Zhang W.
    Prostate; 2020 Jul 30; 80(10):742-752. PubMed ID: 32449811
    [Abstract] [Full Text] [Related]

  • 37. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    Kosaka T, Hongo H, Oya M.
    BMC Cancer; 2019 Jun 11; 19(1):562. PubMed ID: 31185946
    [Abstract] [Full Text] [Related]

  • 38. Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.
    Lam HM, Ouyang B, Chen J, Ying J, Wang J, Wu CL, Jia L, Medvedovic M, Vessella RL, Ho SM.
    Endocr Relat Cancer; 2014 Jun 11; 21(6):903-14. PubMed ID: 25287069
    [Abstract] [Full Text] [Related]

  • 39. Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients.
    Worroll D, Galletti G, Gjyrezi A, Nanus DM, Tagawa ST, Giannakakou P.
    Phys Biol; 2019 Mar 22; 16(3):036003. PubMed ID: 30763921
    [Abstract] [Full Text] [Related]

  • 40. Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145).
    Jangravi Z, Tabar MS, Mirzaei M, Parsamatin P, Vakilian H, Alikhani M, Shabani M, Haynes PA, Goodchild AK, Gourabi H, Baharvand H, Salekdeh GH.
    J Proteome Res; 2015 Sep 04; 14(9):3492-502. PubMed ID: 26215926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.